Inguinal hernia repair with local anesthesia

A comparison between local and spinal anesthesia in inguinal hernia repair

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201403316803N6

Enrollment

Registered

2014-04-09

Start date

2013-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Local anesthesia. Complication of surgical and medical care, unspecified

Interventions

Treatment - Other

For inguinal hernia repair in control group, spinal anesthesia will be performed with 8 mg bupivacain.

Intervention 1: For inguinal hernia repair in control group, spinal anesthesia will be performed with 8 mg bupivacain. Intervention 2: For inguinal hernia repair in intervention group, local anesthesi

For inguinal hernia repair in intervention group, local anesthesia will be applied through 10 ml 1.5% lidocaine, 30 ml 0.5% bupivacain and 2 ml 1:200,000 epinephrine mixture.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Informed written consent; Age between 18 - 70 years; Elective inguinal hernia. Exclusion criteria: Recurrent hernia; Incarcerated hernia; Hydrocele; Femoral hernia; Bilateral hernia; Pregnancy; Sensitivity to local anesthetic drugs; Diabetes mellitus; Coagulopathy disorder; substance abuse.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Intensity of postoperative pain. Timepoint: At the end of surgery and 3, 6, 12 and 24 hours after surgery. Method of measurement: Visual Analogue Scale.	—

Secondary

Measure	Time frame
Duration of surgery. Timepoint: During surgery. Method of measurement: Questionnaire.;Urinary retention. Timepoint: After surgery. Method of measurement: Questionnaire.;Hematoma in the area of operation. Timepoint: After surgery and at the end of the first week. Method of measurement: Questionnaire.;Surgical site infection. Timepoint: At the end of the first week. Method of measurement: Questionnaire.;Postoperative length of stay. Timepoint: After surgery. Method of measurement: Questionnaire.;Analgesic consumption in the first 24 hours after surgery. Timepoint: In the first 24 hours after surgery. Method of measurement: Questionnaire.	—

Measure

Time frame

Duration of surgery. Timepoint: During surgery. Method of measurement: Questionnaire.;Urinary retention. Timepoint: After surgery. Method of measurement: Questionnaire.;Hematoma in the area of operation. Timepoint: After surgery and at the end of the first week. Method of measurement: Questionnaire.;Surgical site infection. Timepoint: At the end of the first week. Method of measurement: Questionnaire.;Postoperative length of stay. Timepoint: After surgery. Method of measurement: Questionnaire.;Analgesic consumption in the first 24 hours after surgery. Timepoint: In the first 24 hours after surgery. Method of measurement: Questionnaire.

—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026